Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iovance Biotherapeutics (IOVA) Non-cash Items: 2015-2024

Historic Non-cash Items for Iovance Biotherapeutics (IOVA) over the last 5 years, with Dec 2024 value amounting to $14.1 million.

  • Iovance Biotherapeutics' Non-cash Items rose 950.85% to $156.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $156.6 million, marking a year-over-year increase of 950.85%. This contributed to the annual value of $14.1 million for FY2024, which is 16.26% up from last year.
  • According to the latest figures from FY2024, Iovance Biotherapeutics' Non-cash Items is $14.1 million, which was up 16.26% from $12.2 million recorded in FY2023.
  • Iovance Biotherapeutics' Non-cash Items' 5-year high stood at $14.1 million during FY2024, with a 5-year trough of $12.2 million in FY2023.
  • Its 2-year average for Non-cash Items is $13.1 million, with a median of $13.1 million in 2023.
  • Data for Iovance Biotherapeutics' Non-cash Items shows a peak YoY climbed of 16.26% (in 2024) over the last 5 years.
  • Over the past 2 years, Iovance Biotherapeutics' Non-cash Items (Yearly) stood at $12.2 million in 2023, then increased by 16.26% to $14.1 million in 2024.